KALA BIO, Inc.
KALA
Kedudukan dalam Saham
#30748
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Harga Saham
$0.75
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$14.50M
Perubahan (1 hari)
2.78%
Perubahan (1 tahun)
-98.28%
Negara
US
Perdagangan KALA BIO, Inc. (KALA)
Kategori
Healthcare
Sejarah harga saham bagi KALA BIO, Inc. (KALA)
Harga penutupan tertinggi: $0.28 pada 2026-10-01
Harga penutupan terendah: $37.46K pada 2018-01-01
Harga penutupan terendah: $37.46K pada 2018-01-01
Sejarah harga saham KALA BIO, Inc. dari 2018 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -63.88% |
| 2025 | -88.09% |
| 2024 | -12.41% |
| 2023 | -37.21% |
| 2022 | -84.21% |
| 2021 | -79.90% |
| 2020 | 49.13% |
| 2019 | 15.30% |
| 2018 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $757.97 | 7.73% |
CH
|
